Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

309

HTML

2856

Figures (1-6)

109

Tables (1-3)

136

Sum=3410

Jun 7, 2005 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Jun 7, 2005; 11(21): 3245-3249
Published online Jun 7, 2005. doi: 10.3748/wjg.v11.i21.3245

Table 1 Patient characteristics.

	Number of patients (%)
Total number of eligible patients	146 (100)
Sex
Male	87 (60)
Female	59 (40)
Age (yr)
Mean	66
Range	3686
Performance status (WHO)
0	11 (15)
1	53 (72)
2	10 (14)
Tumor histology
Grade 1	24 (16)
Grade 2	89 (61)
Grade 3	33 (23)
Tumor localization
Rectum	125 (86)
Recto sigmoid	21 (14)
T stage
T1	6 (4)
T2	26 (18)
T3	94 (64)
T4	20 (14)
Dukes
A	26 (18)
B	85 (58)
C	25 (17)
D	10 (7)
N stage
0	98 (67)
1	26 (18)
2	22 (15)
Primary tumor	135 (93)
Recurrent tumor	11 (8)
Radiotherapy
Given to N patients (%)	91 (62)
Median dose (range) Gy¹	50 (4867)

¹One patient treated only to 25 Gy.

Citation: Salminen E, Palmu S, Vahlberg T, Roberts PJ, Söderström KO. Increased proliferation activity measured by immunoreactive Ki67 is associated with survival improvement in rectal/recto sigmoid cancer. World J Gastroenterol 2005; 11(21): 3245-3249
URL: https://www.wjgnet.com/1007-9327/full/v11/i21/3245.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i21.3245